Amanote Research
Register
Sign In
First Tissue-Agnostic Drug Approval Issued
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2017-078
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
June 5, 2017
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Debating Drug Approval Decisions
Cancer Discovery
Oncology
Elagolix: First Global Approval
Drugs
Pharmacology
Polatuzumab Vedotin: First Global Approval
Drugs
Pharmacology
Correction To: Ibalizumab: First Global Approval
Drugs
Pharmacology
Erratum To: Brodalumab: First Global Approval
Drugs
Pharmacology
Correction To: Delafloxacin: First Global Approval
Drugs
Pharmacology
Correction To: Camrelizumab: First Global Approval
Drugs
Pharmacology
Correction To: Polatuzumab Vedotin: First Global Approval
Drugs
Pharmacology
Congress Turns Spotlight on US Drug Approval Agency
Nature
Multidisciplinary